Syneos Health Inc. (SYNH)
NASDAQ: SYNH
· Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Sep 27, 2023, 10:00 PM
Syneos Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.42B | 5.41B | 5.39B | 5.41B | 5.42B | 5.34B | 5.21B | 4.98B | 4.73B | 4.46B |
Cost of Revenue | 4.22B | 4.18B | 4.14B | 4.12B | 4.14B | 4.09B | 3.99B | 3.82B | 3.61B | 3.42B |
Gross Profit | 1.2B | 1.23B | 1.25B | 1.28B | 1.28B | 1.25B | 1.22B | 1.16B | 1.12B | 1.04B |
Operating Income | 290.7M | 365.08M | 403.19M | 439.56M | 435.07M | 402.16M | 389.28M | 368.51M | 353.9M | 305.19M |
Interest Income | 3.81M | 2.13M | 1.61M | 342K | 39K | 3K | 71K | 71K | 71K | 193K |
Pretax Income | 82.89M | 185.91M | 314.56M | 390.56M | 374.29M | 321.64M | 315.16M | 285.32M | 252.28M | 208.89M |
Net Income | 71.22M | 148.17M | 266.5M | 286.93M | 278.12M | 242.28M | 234.83M | 250.76M | 235.93M | 197.94M |
Selling & General & Admin | 612.09M | 568.61M | 547.25M | 558.82M | 567.99M | 573.62M | 570.76M | 529.95M | 501.52M | 461.83M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 184.5M | 246.56M | 182.17M | 122.7M | 64.11M | 1.59M | 5.88M | 3.5M | -518K | 393K |
Operating Expenses | 856.76M | 815.17M | 794.43M | 807.48M | 811.39M | 813.51M | 806.39M | 756.63M | 727.39M | 686.01M |
Interest Expense | 111.4M | 91.62M | 81.13M | 72.49M | 67.13M | 71.65M | 79.21M | 85.47M | 89.14M | 88.21M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.08B | 5B | 4.93B | 4.93B | 4.95B | 4.91B | 4.8B | 4.57B | 4.33B | 4.11B |
Income Tax Expense | 11.67M | 37.74M | 48.07M | 103.63M | 96.16M | 79.36M | 80.33M | 34.57M | 16.35M | 10.96M |
Shares Outstanding (Basic) | 103.68M | 103.33M | 102.91M | 102.73M | 102.6M | 103.67M | 103.72M | 103.56M | 103.94M | 104.27M |
Shares Outstanding (Diluted) | 104.34M | 103.33M | 103.22M | 103.21M | 103.07M | 104.41M | 105M | 104.78M | 105.02M | 105.46M |
EPS (Basic) | 0.70 | 1.44 | 2.58 | 2.77 | 2.68 | 2.33 | 2.26 | 2.41 | 2.26 | 1.90 |
EPS (Diluted) | 0.69 | 1.43 | 2.57 | 2.75 | 2.66 | 2.31 | 2.24 | 2.39 | 2.24 | 1.88 |
EBITDA | 548.97M | 623.19M | 674.67M | 724.6M | 718.01M | 674.79M | 653.67M | 635.5M | 622.34M | 580.55M |
EBIT | 269.61M | 352.86M | 395.69M | 463.05M | 441.42M | 393.29M | 394.37M | 370.8M | 341.43M | 297.1M |
Depreciation & Amortization | 246.75M | 258.11M | 258.73M | 265.1M | 252.87M | 239.89M | 235.63M | 226.68M | 225.87M | 224.18M |